Bart Cornelissen - Xencor Senior CFO

XNCR Stock  USD 25.01  0.91  3.78%   

CFO

Bart Cornelissen is Senior CFO of Xencor Inc
Address 465 North Halstead Street, Pasadena, CA, United States, 91107
Phone626 305 5900
Webhttps://www.xencor.com

Xencor Management Efficiency

The company has return on total asset (ROA) of (0.1524) % which means that it has lost $0.1524 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2902) %, meaning that it created substantial loss on money invested by shareholders. Xencor's management efficiency ratios could be used to measure how well Xencor manages its routine affairs as well as how well it operates its assets and liabilities. As of 11/23/2024, Return On Tangible Assets is likely to drop to -0.14. In addition to that, Return On Capital Employed is likely to grow to -0.15. At this time, Xencor's Non Current Assets Total are relatively stable compared to the past year. As of 11/23/2024, Non Currrent Assets Other is likely to grow to about 68.5 M, while Total Current Assets are likely to drop slightly above 326.5 M.
Xencor Inc currently holds 83.43 M in liabilities with Debt to Equity (D/E) ratio of 0.06, which may suggest the company is not taking enough advantage from borrowing. Xencor Inc has a current ratio of 7.65, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Xencor's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Found 4 records

CFO Age

Michael CPALarimar Therapeutics
65
Adam LevyMineralys Therapeutics, Common
46
Edward AlbiniSutro Biopharma
66
Edward MBASutro Biopharma
66
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. Xencor, Inc. was incorporated in 1997 and is headquartered in Monrovia, California. Xencor operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 254 people. Xencor Inc (XNCR) is traded on NASDAQ Exchange in USA. It is located in 465 North Halstead Street, Pasadena, CA, United States, 91107 and employs 280 people. Xencor is listed under Biotechnology category by Fama And French industry classification.

Management Performance

Xencor Inc Leadership Team

Elected by the shareholders, the Xencor's board of directors comprises two types of representatives: Xencor inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Xencor. The board's role is to monitor Xencor's management team and ensure that shareholders' interests are well served. Xencor's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Xencor's outside directors are responsible for providing unbiased perspectives on the board's policies.
Nancy MD, Executive Officer
Dane CFA, Senior Strategy
Jennifer Sandoz, Senior Resources
John Desjarlais, Chief Scientific Officer and Sr. VP of Research
Bart Cornelissen, Senior CFO
Bassil Dahiyat, Co-Founder, CEO and President and Director
Kirk RAC, Senior Assurance
John Kuch, VP of Fin.
Eric Kowack, Senior Management
Jeremy Grunstein, Vice President of Business Development
Celia JD, General VP
Charles Liles, Associate Relations

Xencor Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Xencor a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Xencor

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Xencor position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Xencor will appreciate offsetting losses from the drop in the long position's value.

Moving against Xencor Stock

  0.87VALN Valneva SE ADRPairCorr
  0.85AGL agilon healthPairCorr
  0.79MTEM Molecular TemplatesPairCorr
  0.77MRK Merck Company Fiscal Year End 6th of February 2025 PairCorr
  0.74BACK IMAC HoldingsPairCorr
The ability to find closely correlated positions to Xencor could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Xencor when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Xencor - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Xencor Inc to buy it.
The correlation of Xencor is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Xencor moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Xencor Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Xencor can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Xencor Stock Analysis

When running Xencor's price analysis, check to measure Xencor's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xencor is operating at the current time. Most of Xencor's value examination focuses on studying past and present price action to predict the probability of Xencor's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xencor's price. Additionally, you may evaluate how the addition of Xencor to your portfolios can decrease your overall portfolio volatility.